TPW 6.17 Clinicopathological Characteristics and Survival Outcomes of Gastric Hepatoid Adenocarcinoma: A Multicenter Retrospective Study
British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)
DOI: 10.1093/bjs/znag087.370 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Fanghui Ding und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To investigate the clinicopathological characteristics, immunohistochemical features, treatment patterns, and survival outcomes of patients with gastric hepatoid adenocarcinoma (HAS).
Methods
Clinicopathological data of 37 patients diagnosed with HAS between July 2008 and February 2023 were retrospectively collected from seven medical centers. Demographic characteristics, clinical presentations, pathological and immunohistochemical findings, treatment strategies, and prognostic outcomes were analyzed.
Results
Among the 37 patients, 30 were male and 7 were female, with a mean age of 61.95 years. Abdominal pain was the most common initial symptom. Elevated serum alpha-fetoprotein levels were observed in 21 patients. Thirty patients underwent surgical treatment, including 27 radical and 3 palliative procedures. Tumor stages I, II, III, and IV accounted for 1, 6, 18, and 12 cases, respectively. Immunohistochemical positivity rates were 51.35% for GPC-3, 32.43% for HepPar-1, 16.22% for SALL4, and 13.51% for CDX-2. Five patients who received six or more cycles of postoperative adjuvant chemotherapy achieved favourable survival outcomes, with the longest survival reaching 54 months.
Conclusions
HAS is a rare and aggressive subtype of gastric cancer, predominantly affecting elderly men and often presenting at an advanced stage. Radical surgery remains the cornerstone of treatment, and postoperative adjuvant chemotherapy with more than six cycles may contribute to improved long-term survival.
Zitieren
APA
Ding, F., Guan, Q., Wang, F., Zhang, J., & Li, X. (2026). TPW 6.17 Clinicopathological Characteristics and Survival Outcomes of Gastric Hepatoid Adenocarcinoma: A Multicenter Retrospective Study. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.370
Vancouver
Ding F, Guan Q, Wang F, Zhang J, Li X. TPW 6.17 Clinicopathological Characteristics and Survival Outcomes of Gastric Hepatoid Adenocarcinoma: A Multicenter Retrospective Study. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.370
BibTeX
@article{Ding2026,
author = {Ding, Fanghui and Guan, Quanlin and Wang, Fanghong and Zhang, Jianling and Li, Xun},
title = {TPW 6.17 Clinicopathological Characteristics and Survival Outcomes of Gastric Hepatoid Adenocarcinoma: A Multicenter Retrospective Study},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_8},
doi = {10.1093/bjs/znag087.370}
}
EUVIMED